Shenzhen Kangtai Biological Products manufactures vaccines, including a 13-valent pneumococcal conjugate vaccine, recombinant hepatitis B vaccine, DTaP-Hib combination vaccine, 23-valent pneumococcal polysaccharide vaccine, and an inactivated Vero-cell COVID-19 vaccine, supplying markets across Africa, Asia, the Americas, Europe, and the Middle East.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen